Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.53 (
sialidase
)
2,694
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
PNS
axons have a high intrinsic regenerative ability, whereas most CNS axons show little regenerative response. We show that activation of Neu3
sialidase
, also known as Neuraminidase-3, causing conversion of GD1a and GT1b to GM1 ganglioside, is an essential step in regeneration occurring in
PNS
(sensory) but not CNS (retinal) axons in adult rat. In
PNS
axons, axotomy activates Neu3
sialidase
, increasing the ratio of GM1/GD1a and GM1/GT1b gangliosides immediately after injury in vitro and in vivo. No change in the GM1/GD1a ratio after axotomy was observed in retinal axons (in vitro and in vivo), despite the presence of Neu3
sialidase
. Externally applied
sialidase
converted GD1a ganglioside to GM1 and rescued axon regeneration in CNS axons and in
PNS
axons after Neu3
sialidase
blockade. Neu3
sialidase
activation in DRGs is initiated by an influx of extracellular calcium, activating P38MAPK and then Neu3
sialidase
. Ganglioside conversion by Neu3
sialidase
further activates the ERK pathway. In CNS axons, P38MAPK and Neu3
sialidase
were not activated by axotomy.
...
PMID:Neu3 sialidase-mediated ganglioside conversion is necessary for axon regeneration and is blocked in CNS axons. 2496 66